

May 14 (Reuters) - GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Ph...


(Alliance News) - London's FTSE was called down on Wednesday following criticisms from China on the US-UK trade deal being detrimental to third-party ...


(Sharecast News) - GSK announced on Wednesday that it has entered into an agreement with Boston Pharmaceuticals to acquire its lead asset Efimosfermin...


EU, Denmark assess impact, warn of uncertainty *


UK jobs market cools further *


(Alliance News) - GSK PLC on Tuesday said it is ending the development programme for monoclonal antibody belrestotug.


(Sharecast News) - Shares in pharmaceutical companies fell on Monday after US President Donald Trump threatened to sign an executive order to slash th...


MILAN, May 12 (Reuters) - European drugmakers stocks fell in early trading on Monday after U.S. President Donald Trump said he would sign an executi...